Telemedical Coaching for Weight Loss
Fit
TeleLifestyleCoaching Study - Telemedical Coaching for Weight Loss
2 other identifiers
interventional
100
1 country
1
Brief Summary
Lifestyle changes often fail due to loss of motivation. Telemedicine and personal coaching have the potential to support lifestyle change and weight loss. Therefore, the aim of our randomized controlled trial is to examine the effect of telemedicine with and without coaching in comparison to a control group on weight loss in overweight participants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2013
CompletedFirst Posted
Study publicly available on registry
April 22, 2013
CompletedStudy Start
First participant enrolled
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedMay 29, 2014
May 1, 2014
2 months
April 15, 2013
May 28, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
weight loss
Weight will be measured at baseline and after 12 weeks.
12 weeks
Secondary Outcomes (3)
cardiometabolic risk factors
12 weeks
quality of life
12 weeks
physical activity
12 weeks
Other Outcomes (1)
eating behaviour
12 weeks
Study Arms (3)
control (C) group
NO INTERVENTIONThe control group will remain in routine care for 12 weeks. After 12 weeks they will also be given a weighing machine and a step counter, with automatic transfer into a personalized online portal, which can be monitored from both, the participant and the study centre. During the next 12 weeks they will get care calls from the study centre aiming to discuss measured data and to fix target agreements.
telemedical (TM) group
EXPERIMENTALParticipants in the telemedical (TM) group will get a weighing machine and a step counter, with automatic transfer into a personalized online portal, which can be monitored from both, the participant and the study centre.
telemedical coaching (TMC) group
EXPERIMENTALParticipants in the telemedical coaching (TMC) group will get a weighing machine and a step counter, with automatic transfer into a personalized online portal, which can be monitored from both, the participant and the study centre. Additionally, they will be called once per week for 12 weeks from the study centre aiming to discuss measured data and to fix target agreements. After 12 weeks the care calls be be given once per month for further 9 months.
Interventions
telemedical devices (weighing machine and step counter)
care calls once per week for 12 weeks
Eligibility Criteria
You may qualify if:
- employed at Boehringer Ingelheim Pharma GmbH for at least 2 years
- older than 40 years
- overweight or obese or metabolic syndrome
You may not qualify if:
- not willing to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West-German Centre of Diabetes and Health
Düsseldorf, 40591, Germany
Related Publications (1)
Kempf K, Rohling M, Martin S, Schneider M. Telemedical coaching for weight loss in overweight employees: a three-armed randomised controlled trial. BMJ Open. 2019 Apr 11;9(4):e022242. doi: 10.1136/bmjopen-2018-022242.
PMID: 30975666DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephan Martin, MD
West-German Centre of Diabetes and Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of the West German Center of Diabetes and Health
Study Record Dates
First Submitted
April 15, 2013
First Posted
April 22, 2013
Study Start
May 1, 2013
Primary Completion
July 1, 2013
Study Completion
April 1, 2014
Last Updated
May 29, 2014
Record last verified: 2014-05